BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu C, Gong F, Pang P, Shen M, Zhu K, Cheng D, Liu Z, Shan H. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice. PLoS One. 2013;8:e66416. [PMID: 23922634 DOI: 10.1371/journal.pone.0066416] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Subhan MA, Attia SA, Torchilin VP. Advances in siRNA delivery strategies for the treatment of MDR cancer. Life Sci 2021;274:119337. [PMID: 33713664 DOI: 10.1016/j.lfs.2021.119337] [Reference Citation Analysis]
2 Lee SJ, Kim MJ, Kwon IC, Roberts TM. Delivery strategies and potential targets for siRNA in major cancer types. Adv Drug Deliv Rev 2016;104:2-15. [PMID: 27259398 DOI: 10.1016/j.addr.2016.05.010] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 10.5] [Reference Citation Analysis]
3 Jiang H, Islam MA, Xing L, Firdous J, Cao W, He Y, Zhu Y, Cho K, Li H, Cho C. Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy. Top Curr Chem (Z) 2017;375. [DOI: 10.1007/s41061-017-0124-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
4 Zhang H, Deng L, Liu H, Mai S, Cheng Z, Shi G, Zeng H, Wu Z. Enhanced fluorescence/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100220] [Reference Citation Analysis]
5 Sun Y, Ye X, Cai M, Liu X, Xiao J, Zhang C, Wang Y, Yang L, Liu J, Li S, Kang C, Zhang B, Zhang Q, Wang Z, Hong A, Wang X. Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery. ACS Nano 2016;10:5759-68. [PMID: 27176123 DOI: 10.1021/acsnano.5b07828] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
6 Fedotcheva TA, Olenin AY, Starostin KM, Lisichkin GV, Banin VV, Shimanovskii NL. Prospects for Using Gold, Silver, and Iron Oxide Nanoparticles for Increasing the Efficacy of Chemotherapy. Pharm Chem J 2015;49:220-30. [DOI: 10.1007/s11094-015-1260-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
7 Varshosaz J, Farzan M. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12022-12041 [PMID: 26576089 DOI: 10.3748/wjg.v21.i42.12022] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
8 Subhan MA, Torchilin V. Efficient nanocarriers of siRNA therapeutics for cancer treatment. Translational Research 2019;214:62-91. [DOI: 10.1016/j.trsl.2019.07.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
9 Lellouche E, Israel LL, Bechor M, Attal S, Kurlander E, Asher VA, Dolitzky A, Shaham L, Izraeli S, Lellouche JP, Michaeli S. MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs. Bioconjug Chem 2015;26:1692-701. [PMID: 26056709 DOI: 10.1021/acs.bioconjchem.5b00276] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang K, Kievit FM, Sham JG, Jeon M, Stephen ZR, Bakthavatsalam A, Park JO, Zhang M. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. Small 2016;12:477-87. [PMID: 26641029 DOI: 10.1002/smll.201501985] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
11 Gupta N, Rai DB, Jangid AK, Pooja D, Kulhari H. Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers. In: Singh S, Maurya PK, editors. Nanotechnology in Modern Animal Biotechnology. Singapore: Springer; 2019. pp. 67-114. [DOI: 10.1007/978-981-13-6004-6_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wu Z, Xu XL, Zhang JZ, Mao XH, Xie MW, Cheng ZL, Lu LJ, Duan XH, Zhang LM, Shen J. Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro. Nanomaterials (Basel) 2017;7:E110. [PMID: 28492491 DOI: 10.3390/nano7050110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
13 Yan JJ, Liao JZ, Lin JS, He XX. Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems. Tumour Biol. 2015;36:55-67. [PMID: 25424700 DOI: 10.1007/s13277-014-2855-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
14 Mohan A, Nair SV, Lakshmanan V. Polymeric nanomicelles for cancer theragnostics. International Journal of Polymeric Materials and Polymeric Biomaterials 2017;67:119-30. [DOI: 10.1080/00914037.2017.1309540] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Scarabel L, Perrone F, Garziera M, Farra R, Grassi M, Musiani F, Russo Spena C, Salis B, De Stefano L, Toffoli G, Rizzolio F, Tonon F, Abrami M, Chiarappa G, Pozzato G, Forte G, Grassi G, Dapas B. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells. Expert Opinion on Drug Delivery 2017;14:797-810. [DOI: 10.1080/17425247.2017.1292247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
16 Zhang K, Yu M, Hao F, Dong A, Chen D. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo. Cancer Biomark 2016;17:281-91. [PMID: 27802204 DOI: 10.3233/CBM-160640] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
17 Özdemir F, Akalın G, Şen M, Önder NI, Işcan A, Kutlu HM, Incesu Z. Towards novel anti-tumor strategies for hepatic cancer: ɛ-viniferin in combination with vincristine displays pharmacodynamic synergy at lower doses in HepG2 cells. OMICS 2014;18:324-34. [PMID: 24341688 DOI: 10.1089/omi.2013.0045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
18 Laurent S, Saei AA, Behzadi S, Panahifar A, Mahmoudi M. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv. 2014;11:1449-1470. [PMID: 24870351 DOI: 10.1517/17425247.2014.924501] [Cited by in Crossref: 245] [Cited by in F6Publishing: 211] [Article Influence: 30.6] [Reference Citation Analysis]
19 Ngamcherdtrakul W, Castro DJ, Gu S, Morry J, Reda M, Gray JW, Yantasee W. Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment. Cancer Treat Rev 2016;45:19-29. [PMID: 26930249 DOI: 10.1016/j.ctrv.2016.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
20 Wang J, Ren L, Li J, Huang J, Cheng D, Shuai X. Effective siRNA therapy of hepatoma mediated by a nonviral vector with MRI-visibility and biodegradability. RSC Adv 2015;5:21103-11. [DOI: 10.1039/c4ra16870d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
21 Tarhan S, Özdemir F, İncesu Z, Demirkan ES. Direct and protective effects of single or combined addition of vincristine and ε-viniferin on human HepG2 cellular oxidative stress markers in vitro. Cytotechnology 2016;68:1081-94. [PMID: 26228177 DOI: 10.1007/s10616-015-9863-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Dolci S, Domenici V, Vidili G, Orecchioni M, Bandiera P, Madeddu R, Farace C, Peana M, Tiné MR, Manetti R, Sgarrella F, Delogu LG. Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography. RSC Adv 2016;6:2712-23. [DOI: 10.1039/c5ra19652c] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Gehrig S, Sami H, Ogris M. Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics. Therapeutic Delivery 2014;5:1275-96. [DOI: 10.4155/tde.14.87] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
24 Cai M, Yang L, Zhang S, Liu J, Sun Y, Wang X. A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy. Int J Nanomedicine 2017;12:7469-82. [PMID: 29075114 DOI: 10.2147/IJN.S139775] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
25 Subhan MA, Torchilin VP. siRNA based drug design, quality, delivery and clinical translation. Nanomedicine 2020;29:102239. [PMID: 32544449 DOI: 10.1016/j.nano.2020.102239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
26 Kapilov-Buchman Y, Lellouche E, Michaeli S, Lellouche JP. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry. Bioconjug Chem 2015;26:880-9. [PMID: 25830668 DOI: 10.1021/acs.bioconjchem.5b00100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
27 Scomparin A, Polyak D, Krivitsky A, Satchi-Fainaro R. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation. Biotechnol Adv 2015;33:1294-309. [PMID: 25916823 DOI: 10.1016/j.biotechadv.2015.04.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
28 Farra R, Musiani F, Perrone F, Čemažar M, Kamenšek U, Tonon F, Abrami M, Ručigaj A, Grassi M, Pozzato G, Bonazza D, Zanconati F, Forte G, El Boustani M, Scarabel L, Garziera M, Russo Spena C, De Stefano L, Salis B, Toffoli G, Rizzolio F, Grassi G, Dapas B. Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness. Molecules 2018;23:E777. [PMID: 29597300 DOI: 10.3390/molecules23040777] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Oral O, Cıkım T, Zuvin M, Unal O, Yagci-acar H, Gozuacik D, Koşar A. Effect of Varying Magnetic Fields on Targeted Gene Delivery of Nucleic Acid-Based Molecules. Ann Biomed Eng 2015;43:2816-26. [DOI: 10.1007/s10439-015-1331-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]